You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 26, 2024

Litigation Details for Bristol-Myers Squibb Company v. Aurobindo Pharma USA Inc. (D. Del. 2017)

✉ Email this page to a colleague

« Back to Dashboard

Bristol-Myers Squibb Company v. Aurobindo Pharma USA Inc. (D. Del. 2017)

Docket	⤷ Try a Trial	Date Filed	2017-04-05
Court	District Court, D. Delaware	Date Terminated
Cause	35:271 Patent Infringement	Assigned To	Leonard Philip Stark
Jury Demand	None	Referred To
Parties	ACCORD HEALTHCARE INC.; APOTEX CORP.; APOTEX INC.; AUROBINDO PHARMA LTD.; AUROBINDO PHARMA USA INC.; BIONPHARMA INC.; BRISTOL-MYERS SQUIBB COMPANY; DR. REDDY'S LABORATORIES INC.; DR. REDDY'S LABORATORIES LTD.; EMCURE PHARMACEUTICALS LTD.; HEC PHARM USA INC.; HETERO LABS LTD.; HETERO LABS LTD. UNIT-V; HETERO USA INC.; IMPAX LABORATORIES INC.; IMPAX LABORATORIES LLC; INDOCO REMEDIES LTD.; INVAGEN PHARMACEUTICALS INC.; LUPIN LTD.; MACLEODS PHARMACEUTICALS LTD.; MICRO LABS LTD.; MICRO LABS USA INC.; MYLAN PHARMACEUTICALS INC.; NATCO PHARMA LTD.; PFIZER INC.; PRINSTON PHARMACEUTICAL INC.; SANDOZ INC.; SIGMAPHARM LABORATORIES LLC; SUN PHARMA GLOBAL FZE; SUN PHARMACEUTICAL INDUSTRIES INC.; SUNSHINE LAKE LLC; SUNSHINE LAKE PHARMA CO. LTD.; TORRENT PHARMACEUTICALS LTD.; UNICHEM LABORATORIES, LTD.; WOCKHARDT BIO AG; WOCKHARDT USA LLC; ZYDUS PHARMACEUTICALS (USA) INC.
Patents	6,017,927; 6,967,208; 9,326,945; 9,943,579
Attorneys	A. Neal Seth; Adam Wyatt Poff; Alexis Cohen; Amy K. Wigmore; Andrew J. Danford; Andrew J. Miller; Annaleigh E. Curtis; Anthony J. Fitzpatrick; Arthur G. Connolly , III; Arun John Mohan; Bindu Ann George Palapura; Brandon M. White; Brian E. Farnan; C. Kyle Musgrove; Carolyn A. Alenci; Carolyn A. Blessing; Charles T. Cox , Jr.; Christa J. Laser; David A. Bilson; David A. Gerasimow; David B. Abramowitz; David Ellis Moore; David Jay; Dean L. Fanelli; Devan V Padmanabhan; Dominick T. Gattuso; Don J. Mizerk; Douglas R. Weider; Dustin L. Taylor; Elena Endrukaite; Elizabeth M. Crompton; Erin M. Forbes; Erin R. Conway; Eve H. Ormerod; Gregory Erich Stuhlman; Heather M. Petruzzi; Jamaica P. Szeliga; Jeffrey T. Hantson; Jennifer M. Rutter; Jill M. Browning; John C. Phillips , Jr.; John M. Seaman; Jonathan B. Turpin; Joseph E. Cwik; Joseph J. Farnan , Jr.; Karen L. Carroll; Karen L. Pascale; Katherine P. Kieckhafer; Katie A. Boda; Keith D. Parr; Kenneth Laurence Dorsney; Kevin M. Capuzzi; Kevin M. Yurkerwich; Kevin P. Burke; Kevin S. Prussia; Kimberly A. Beis; Madeleine C. Laupheimer; Maegan A. Fuller; Manish K. Mehta; Marc R. Wezowski; Matthew M. Holub; Melanie B. Dubis; Michael Choi; Michael J. Farnan; Michael J. Fink; Michael J. Gaertner; Michael Nelson; Micheal L. Binns; Natco Pharma Ltd.; Neal C. Belgam; Nina Vachhani; P. Branko Pejic; Paul A. Braier; Paul H. Kochanski; Philip D. Segrest; Rachel K. Hunnicutt; Richard L. Renck; Robert L. Florence; Scott Cunning; Sean M. Brennecke; Sharad K. Bijanki; Shirley Cantin; Sri K. Sankaran; Stamatios Stamoulis; Stephanie E. O'Byrne; Stephen B. Brauerman; Stephen P. Benson; Steven J. Moore; Stuart D. Sender; Tara M. Raghaven; Thomas A. Haag; Thomas P. Heneghan; Thomas R. Burns; Timothy Cook; Tracey C. Allen; Vincent L. Capuano; Wenbo Zhang; Wenli Gu; William A. Rakoczy; William F. Lee; Zaiba Baig
Firms	Abrams & Bayliss LLP; Bayard, P.A.; Benesch Friedlander Coplan & Aronoff LLP; Connolly Gallagher LLP; Duane Morris, LLP; Farnan LLP; Greenberg Traurig, the Nemours Building; Heyman Enerio Gattuso & Hirzel LLP; Klehr Harrison Harvey Branzburg & Ellers; Phillips, Goldman, McLaughlin & Hall, P.A.; Schiff Hardin LLP; Smith, Katzenstein, & Jenkins LLP; Stamoulis & Weinblatt LLC; Young, Conaway, Stargatt & Taylor LLP
Link to Docket	External link to docket

Small Molecule Drugs cited in Bristol-Myers Squibb Company v. Aurobindo Pharma USA Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial and ⤷ Try a Trial .

Biologic Drugs cited in Bristol-Myers Squibb Company v. Aurobindo Pharma USA Inc.

The biologic drug covered by the patents cited in this case is ⤷ Try a Trial .

Details for Bristol-Myers Squibb Company v. Aurobindo Pharma USA Inc. (D. Del. 2017)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Try a Trial
Date Filed	Document No.	Description	Snippet	Link To Document
2017-06-15	12		IV) for U.S. Patent Nos. 6,967,208 (“the ’208 patent”) and 9,326,945 (“the ’945 patent”). Aurobindo … (Noninfringement of U.S. Patent No. 6,967,208) Plaintiffs will not and cannot…Invalidity of U.S. Patent No. 6,967,208) Upon… purports to bring an action for patent infringement under the Patent Laws, 35 U.S.C. § 100 et seq… PATENTS-IN-SUIT 9. Aurobindo admits that the ’208 patent is entitled “	External link to document
2018-04-21	144		Invalidity Contentions Relating to U.S. Patent No. 6,967,208 filed by Mylan Pharmaceuticals Inc..(Stamoulis… 5 April 2017 1:17-cv-00374-LPS Patent None District Court, D. Delaware	External link to document
2018-04-21	145		Invalidity Contentions Relating to U.S. Patent No. 9,326,945 filed by Mylan Pharmaceuticals Inc..(Stamoulis… 5 April 2017 1:17-cv-00374-LPS Patent None District Court, D. Delaware	External link to document
2018-10-18	380		of U.S. Patent Nos. 9,326,945 ("'945 patent") and 6,967,208 ('"208 patent")…arts, such as the salts disclosed at U.S . Patent No. 6,967,208, column 116, lines 51-67, and in Remington…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which the…reading the entire patent." Id. at 1321 (internal quotation marks omitted). The patent specification … TERMS A. '208 Patent The '208 patent is entitled "Lactam-containing	External link to document
2017-04-05	4		the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 6,967,208 B2; US 9,326,945 … 5 April 2017 1:17-cv-00374-LPS Patent None District Court, D. Delaware	External link to document
2019-06-20	536	Motion to Strike	MacMillan relating to infringement of U.S. Patent No. 6,967,208, Claim 104 - filed by Sigmapharm Laboratories…5 April 2017 1:17-cv-00374-LPS 830 Patent None District Court, D. Delaware	External link to document
2019-07-01	545	Letter	MacMillan relating to infringement of U.S. Patent No. 6,967,208, Claim 104. (Attachments: # 1 Exhibit A,…5 April 2017 1:17-cv-00374-LPS 830 Patent None District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.